Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 3 Hepatitis 1 Colitis 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

vedolizumab 1 Sofosbuvir 1 Ribavirin 1 Photopheresis 1 Mycophenolic Acid 1 Methoxsalen 1 Infliximab 1 Azathioprine 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Hepatitis × vedolizumab × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡